DO "ANORECTIC" DRUGS PRODUCE WEIGHT LOSS BY APPETITE SUPPRESSION?

M. Kirby,P. Turner

DOI: https://doi.org/10.1016/S0140-6736(76)90360-3

IF: 202.731

1976-03-13

The Lancet

Abstract:

What problem does this paper attempt to address?

Disease progression and clinical outcomes in latent osteoarthritis phenotypes: Data from the Osteoarthritis Initiative

Zeyu Huang,Mary A Bucklin,Weihua Guo,John T Martin

DOI: https://doi.org/10.1101/2023.12.14.23299525

2023-12-15

MedRxiv

Abstract:The prevalence of knee osteoarthritis (OA) is widespread and the heterogeneous patient factors and clinical symptoms in OA patients impede developing personalized treatments for OA patients. In this study, we used unsupervised and supervised machine learning to organize the heterogeneity in knee OA patients and predict disease progression in individuals from the Osteoarthritis Initiative (OAI) dataset. We identified four distinct knee OA phenotypes using unsupervised learning that were defined by nutrition, disability, stiffness, and pain (knee and back) and were strongly related to disease fate. Interestingly, the absence of supplemental vitamins from an individual's diet was protective from disease progression. Moreover, we established a phenotyping tool and prognostic model from 5 variables (WOMAC disability score of the right knee, WOMAC total score of the right knee, WOMAC total score of the left knee, supplemental vitamins and minerals frequency, and antioxidant combination multivitamins frequency) that can be utilized in clinical practice to determine the risk of knee OA progression in individual patients. We also developed a prognostic model to estimate the risk for total knee replacement and provide suggestions for modifiable variables to improve long-term knee health. This combination of unsupervised and supervised data-driven tools provides a framework to identify knee OA phenotype in a clinical scenario and personalize treatment strategies.
A clinical model to predict the progression of knee osteoarthritis: data from Dryad

Lianwei Shen,Shouwei Yue,Lianwei Shen and Shouwei Yue

DOI: https://doi.org/10.1186/s13018-023-04118-4

IF: 2.6

2023-08-29

Journal of Orthopaedic Surgery and Research

Abstract:Knee osteoarthritis (KOA) is a multifactorial, slow-progressing, non-inflammatory degenerative disease primarily affecting synovial joints. It is usually induced by advanced age and/or trauma and eventually leads to irreversible destruction of articular cartilage and other tissues of the joint. Current research on KOA progression has limited clinical application significance. In this study, we constructed a prediction model for KOA progression based on multiple clinically relevant factors to provide clinicians with an effective tool to intervene in KOA progression.

orthopedics
Phenotypes of osteoarthritis-related knee pain and their transition over time: data from the osteoarthritis initiative

Jing Ye,Dongxing Xie,Xiaoxiao Li,Na Lu,Chao Zeng,Guanghua Lei,Jie Wei,Jiatian Li

DOI: https://doi.org/10.1186/s12891-024-07286-4

IF: 2.562

2024-02-25

BMC Musculoskeletal Disorders

Abstract:Identification of knee osteoarthritis (OA) pain phenotypes, their transition patterns, and risk factors for worse phenotypes, may guide prognosis and targeted treatment; however, few studies have described them. We aimed to investigate different pain phenotypes, their transition patterns, and potential risk factors for worse pain phenotypes.

orthopedics,rheumatology
Identifying Robust Risk Factors for Knee Osteoarthritis Progression: An Evolutionary Machine Learning Approach

Christos Kokkotis,Serafeim Moustakidis,Vasilios Baltzopoulos,Giannis Giakas,Dimitrios Tsaopoulos

DOI: https://doi.org/10.3390/healthcare9030260

2021-03-01

Health Care

Abstract:Knee osteoarthritis (KOA) is a multifactorial disease which is responsible for more than 80% of the osteoarthritis disease’s total burden. KOA is heterogeneous in terms of rates of progression with several different phenotypes and a large number of risk factors, which often interact with each other. A number of modifiable and non-modifiable systemic and mechanical parameters along with comorbidities as well as pain-related factors contribute to the development of KOA. Although models exist to predict the onset of the disease or discriminate between asymptotic and OA patients, there are just a few studies in the recent literature that focused on the identification of risk factors associated with KOA progression. This paper contributes to the identification of risk factors for KOA progression via a robust feature selection (FS) methodology that overcomes two crucial challenges: (i) the observed high dimensionality and heterogeneity of the available data that are obtained from the Osteoarthritis Initiative (OAI) database and (ii) a severe class imbalance problem posed by the fact that the KOA progressors class is significantly smaller than the non-progressors’ class. The proposed feature selection methodology relies on a combination of evolutionary algorithms and machine learning (ML) models, leading to the selection of a relatively small feature subset of 35 risk factors that generalizes well on the whole dataset (mean accuracy of 71.25%). We investigated the effectiveness of the proposed approach in a comparative analysis with well-known FS techniques with respect to metrics related to both prediction accuracy and generalization capability. The impact of the selected risk factors on the prediction output was further investigated using SHapley Additive exPlanations (SHAP). The proposed FS methodology may contribute to the development of new, efficient risk stratification strategies and identification of risk phenotypes of each KOA patient to enable appropriate interventions.

health care sciences & services,health policy & services
Multivariate information transmission

W. J. McGill

DOI: https://doi.org/10.1109/TIT.1954.1057469

1954-06-01

Transactions of the IRE Professional Group on Information Theory

Abstract:A multivariate analysis based on transmitted information is presented. It is shown that sample transmitted information provides a simple method for measuring and testing association in multi-dimensional contingency tables. Relations with analysis of variance are pointed out, and statistical tests are described.
Multimodal Machine Learning-based Knee Osteoarthritis Progression Prediction from Plain Radiographs and Clinical Data

Aleksei Tiulpin,Stefan Klein,Sita M.A. Bierma-Zeinstra,Jérôme Thevenot,Esa Rahtu,Joyce van Meurs,Edwin H.G. Oei,Simo Saarakkala

DOI: https://doi.org/10.48550/arXiv.1904.06236

2019-05-06

Abstract:Knee osteoarthritis (OA) is the most common musculoskeletal disease without a cure, and current treatment options are limited to symptomatic relief. Prediction of OA progression is a very challenging and timely issue, and it could, if resolved, accelerate the disease modifying drug development and ultimately help to prevent millions of total joint replacement surgeries performed annually. Here, we present a multi-modal machine learning-based OA progression prediction model that utilizes raw radiographic data, clinical examination results and previous medical history of the patient. We validated this approach on an independent test set of 3,918 knee images from 2,129 subjects. Our method yielded area under the ROC curve (AUC) of 0.79 (0.78-0.81) and Average Precision (AP) of 0.68 (0.66-0.70). In contrast, a reference approach, based on logistic regression, yielded AUC of 0.75 (0.74-0.77) and AP of 0.62 (0.60-0.64). The proposed method could significantly improve the subject selection process for OA drug-development trials and help the development of personalized therapeutic plans.

Computer Vision and Pattern Recognition
Predicting the onset of end-stage knee osteoarthritis over two- and five-years using machine learning

Zubeyir Salis,Jeffrey B. Driban,Timothy E. McAlindon

DOI: https://doi.org/10.1016/j.semarthrit.2024.152433

IF: 5.431

2024-03-17

Seminars in Arthritis and Rheumatism

Abstract:Summary Objective Identifying participants who will progress to advanced stage in knee osteoarthritis (KOA) trials remains a significant challenge. Current tools, relying on total knee replacements (TKR), fall short in reliability due to the extraneous factors influencing TKR decisions. Acknowledging these limitations, our study identifies a critical need for a more robust metric to assess severe KOA. The end-stage KOA (esKOA) measure, which combines symptomatic and radiographic criteria, serves as a solid indicator. To enhance future trials that use esKOA as an endpoint, our study focuses on developing and validating a machine-learning tool to identify individuals likely to develop esKOA within 2 to 5 years. Design Utilizing the Osteoarthritis Initiative (OAI) data, we trained models on 3,114 participants and validated them with 606 participants for the right knee, and similarly for the left knee, with external validation from the Multicentre Osteoarthritis Study (MOST) involving 1,602 participants. We aimed to predict esKOA onset at 2-to-2.5 years and 4-to-5 years, defining esKOA by severe radiographic KOA with moderate/severe symptoms or mild/moderate radiographic KOA with persistent/intense symptoms. Our analysis considered 51 candidate predictors, including demographics, clinical history, physical examination, and X-ray evaluations. An online tool predicting esKOA progression, based on models with ten and nine predictors for the right and left knees, respectively, was developed. Results External validation (MOST) for the right knee at 2.5 years yielded an Area Under Curve (AUC) of 0.847 (95% CI 0.811 to 0.882), and at 5 years, 0.853 (95% CI 0.823 to 0.881); for the left knee at 2.5 years, AUC was 0.824 (95% CI 0.782 to 0.857), and at 5 years, 0.807 (95% CI 0.768 to 0.843). Models with fewer predictors demonstrated comparable performance. The online tool is available at: https://eskoa.shinyapps.io/webapp/ . Conclusion Our study unveils a robust, externally validated machine learning tool proficient in predicting the onset of esKOA over the next 2 to 5 years. Our tool can lead to more efficient KOA trials.

rheumatology
Data-driven identification of predictive risk biomarkers for subgroups of osteoarthritis using interpretable machine learning

Rikke Linnemann Nielsen,Thomas Monfeuga,Robert R. Kitchen,Line Egerod,Luis G. Leal,August Thomas Hjortshøj Schreyer,Frederik Steensgaard Gade,Carol Sun,Marianne Helenius,Lotte Simonsen,Marianne Willert,Abd A. Tahrani,Zahra McVey,Ramneek Gupta

DOI: https://doi.org/10.1038/s41467-024-46663-4

IF: 16.6

2024-04-02

Nature Communications

Abstract:Osteoarthritis (OA) is increasing in prevalence and has a severe impact on patients' lives. However, our understanding of biomarkers driving OA risk remains limited. We developed a model predicting the five-year risk of OA diagnosis, integrating retrospective clinical, lifestyle and biomarker data from the UK Biobank (19,120 patients with OA, ROC-AUC: 0.72, 95%CI (0.71–0.73)). Higher age, BMI and prescription of non-steroidal anti-inflammatory drugs contributed most to increased OA risk prediction ahead of diagnosis. We identified 14 subgroups of OA risk profiles. These subgroups were validated in an independent set of patients evaluating the 11-year OA risk, with 88% of patients being uniquely assigned to one of the 14 subgroups. Individual OA risk profiles were characterised by personalised biomarkers. Omics integration demonstrated the predictive importance of key OA genes and pathways (e.g., GDF5 and TGF-β signalling) and OA-specific biomarkers (e.g., CRTAC1 and COL9A1). In summary, this work identifies opportunities for personalised OA prevention and insights into its underlying pathogenesis.

multidisciplinary sciences
A warning machine learning algorithm for early knee osteoarthritis structural progressor patient screening

Hossein Bonakdari,Afshin Jamshidi,Jean-Pierre Pelletier,François Abram,Ginette Tardif,Johanne Martel-Pelletier

DOI: https://doi.org/10.1177/1759720X21993254

2021-02-24

Therapeutic Advances in Musculoskeletal Disease

Abstract:In osteoarthritis (OA) there is a need for automated screening systems for early detection of structural progressors. We built a comprehensive machine learning (ML) model that bridges major OA risk factors and serum levels of adipokines/related inflammatory factors at baseline for early prediction of at-risk knee OA patient structural progressors over time. The patient- and gender-based model development used baseline serum levels of six adipokines, three related inflammatory factors and their ratios (36), as well as major OA risk factors [age and bone mass index (BMI)]. Subjects (677) were selected from the Osteoarthritis Initiative (OAI) progression subcohort. The probability values of being structural progressors (PVBSP) were generated using our previously published prediction model, including five baseline structural features of the knee, i.e. two X-rays and three magnetic resonance imaging variables. To identify the most important variables amongst the 47 studied in relation to PVBSP, we employed the ML feature classification methodology. Among five supervised ML algorithms, the support vector machine (SVM) demonstrated the best accuracy and use for gender-based classifiers development. Performance and sensitivity of the models were assessed. A reproducibility analysis was performed with clinical trial OA patients. Feature selections revealed that the combination of age, BMI, and the ratios CRP/MCP-1 and leptin/CRP are the most important variables in predicting OA structural progressors in both genders. Classification accuracies for both genders in the testing stage (OAI) were >80%, with the highest sensitivity of CRP/MCP-1. Reproducibility analysis showed an accuracy ⩾92%; the ratio CRP/MCP-1 demonstrated the highest sensitivity in women and leptin/CRP in men. This is the first time that such a framework was built for predicting knee OA structural progressors. Using this automated ML patient- and gender-based model, early prediction of knee structural OA progression can be performed with high accuracy using only three baseline serum biomarkers and two risk factors. Machine learning model for early knee osteoarthritis structural progression Knee osteoarthritis is a well-known debilitating disease leading to reduced mobility and quality of life – the main causes of chronic invalidity. Disease evolution can be slow and span many years; however, for some individuals, the progression/evolution can be fast. Current treatments are only symptomatic and conventional diagnosis of osteoarthritis is not very effective in early identification of patients who will progress rapidly. To improve therapeutic approaches, we need a robust prediction model to stratify osteoarthritis patients at an early stage according to risk of joint structure disease progression. We hypothesize that a prediction model using a machine learning system would enable such an early identification of individuals for whom osteoarthritis knee structure will degrade rapidly. Data were from the Osteoarthritis Initiative, a National Institute of Health (United States) databank, and the robustness and generalizability of the developed model was further evaluated using osteoarthritis patients from an external cohort. Using the supervised machine learning system (support vector machine), we developed an automated patient- and gender-based model enabling an early clinical prognosis for individuals at high risk of structural progressive osteoarthritis. In brief, this model employed at baseline (when the subject sees a physician) easily obtained features consisting of the two main osteoarthritis risk factors, age and bone mass index (BMI), in addition to the serum levels of three molecules. Two of these molecules belong to a family of factors names adipokines and one to a related inflammatory factor. In brief, the model comprising a combination of age, BMI, and the ratios CRP/MCP-1 and leptin/CRP were found very robust for both genders, and the high accuracy persists when tested with an external cohort conferring the gender-based model generalizability. This study offers a new automated system for identifying early knee osteoarthritis structural progressors, which will significantly improve clinical prognosis with real time patient monitoring.

rheumatology
Identifying the Phenotypic and Temporal Heterogeneity of Knee Osteoarthritis: Data From the Osteoarthritis Initiative

Mengjiao Li,Lan Lan,Jiawei Luo,Li Peng,Xiaolong Li,Xiaobo Zhou

DOI: https://doi.org/10.3389/fpubh.2021.726140

IF: 5.2

2021-08-19

Frontiers in Public Health

Abstract:Objective: Previous studies discussing phenotypic and temporal heterogeneity of knee osteoarthritis (KOA) separately have fatal limitations that either clustering patients with similar severity or assuming all knees have a single common progression pattern, which are unreliable. This study tried to uncover more reliable information on phenotypic and temporal heterogeneity of KOA. Design: Data were from Osteoarthritis Initiative database. Six hundred and seventy-eight unilateral knees that have greater Kellgren and Lawrence (KL) grade than the contralateral knees at baseline and in all follow-up 48 months were included. Measurements of biomarkers at baseline were chosen. Subtype and Stage Inference model (SuStaIn) was applied as a subtype-progression model to identify subtypes, subtype biomarker progress sequences and stages of KOA. Results: This study identified three subtypes which account for 15, 61, and 24% of knees, respectively. Each subtype has distinct subtype biomarker progress sequence. For knees with KL grade 0/1, 2, 3, and 4, they have different distributions on stage and 26, 53, 89, and 95% of them are strongly assigned to subtypes. When assessing whether a knee has KL (grade ≥ 2), subtypes and stages from subtypes-progression model (SuStaIn) are significantly better fitting than those from subtypes-only (mixture of Gaussians) (likelihood ratio = 105.59, p = 2.2 × 10 −16 ) or stages-only (SuStaIn where setting c = 1) (likelihood ratio = 58.04, p = 2.57 × 10 −14 ) model. Stages in subtypes-progression model has greater β than stages-only model. Subtypes from subtypes-progression model have no statistical significance. Conclusions: For subtypes-progression model, stages contain more complete temporal information and subtypes are closer to real OA subtypes.

public, environmental & occupational health
Identification of Biomarkers Associated with Diagnosis of Osteoarthritis Patients Based on Bioinformatics and Machine Learning

Yihao Liang,Fangzheng Lin,Yunfei Huang

DOI: https://doi.org/10.1155/2022/5600190

2022-06-13

Abstract:Osteoarthritis (OA) is thought to be the most prevalent chronic joint disease. The incidence of OA is rising because of the ageing population and the epidemic of obesity. This research was designed for the identification of novel diagnostic biomarkers for OA and analyzing the possible association between critical genes and infiltrated immune cells. 10 OA samples from patients with spinal OA and 10 normal samples were collected. GSE55235 and GSE55457 datasets including human OA and normal samples were downloaded from the GEO datasets. Differentially expressed genes (DEGs) were identified between 20 OA and 20 controls. SVM-RFE analysis and LASSO regression model were carried out to screen possible markers. The compositional patterns of the 22 types of immune cell fraction in OA were determined by the use of CIBERSORT. The expression level of the biomarkers in OA was examined by the use of RT-PCR. In this study, an overall 44 DEGs were identified: 18 genes were remarkably upregulated and 26 genes were distinctly downregulated. KEGG pathway analyses revealed that pathways were significantly enriched including IL-17 signal path, rheumatoid arthritis, TNF signal path, and lipid and atherosclerosis. Based on the results of machine learning, we identified APOLD1 and EPYC as critical diagnostic genes in OA, which were further confirmed using ROC assays. Immune cell infiltration analysis revealed that APOLD1 was correlated with mastocytes stimulated, NK cells resting, T cells CD4 memory resting, DCs stimulated, T cells gamma delta, macrophages M0, NK cells stimulated, and mastocytes resting. Moreover, we found that EPYC was correlated with mastocytes stimulated, NK cells resting, T cells CD4 memory resting, DCs stimulated, T cells gamma delta, macrophages M0, NK cells stimulated, and mastocytes resting. Overall, our findings might provide some novel clue for the exploration of novel markers for OA diagnosis. The critical genes and their associations with immune infiltration may offer new insight into understanding OA developments.
Multi-classifier prediction of knee osteoarthritis progression from incomplete imbalanced longitudinal data

Paweł Widera,Paco M. J. Welsing,Christoph Ladel,John Loughlin,Floris P. F. J. Lafeber,Florence Petit Dop,Jonathan Larkin,Harrie Weinans,Ali Mobasheri,Jaume Bacardit

DOI: https://doi.org/10.1038/s41598-020-64643-8

IF: 4.6

2020-05-21

Scientific Reports

Abstract:Abstract Conventional inclusion criteria used in osteoarthritis clinical trials are not very effective in selecting patients who would benefit from a therapy being tested. Typically majority of selected patients show no or limited disease progression during a trial period. As a consequence, the effect of the tested treatment cannot be observed, and the efforts and resources invested in running the trial are not rewarded. This could be avoided, if selection criteria were more predictive of the future disease progression. In this article, we formulated the patient selection problem as a multi-class classification task, with classes based on clinically relevant measures of progression (over a time scale typical for clinical trials). Using data from two long-term knee osteoarthritis studies OAI and CHECK, we tested multiple algorithms and learning process configurations (including multi-classifier approaches, cost-sensitive learning, and feature selection), to identify the best performing machine learning models. We examined the behaviour of the best models, with respect to prediction errors and the impact of used features, to confirm their clinical relevance. We found that the model-based selection outperforms the conventional inclusion criteria, reducing by 20–25% the number of patients who show no progression. This result might lead to more efficient clinical trials.

multidisciplinary sciences
Insights into osteoarthritis progression revealed by analyses of both knee tibiofemoral compartments

C.-H. Chou,M.T.M. Lee,I.-W. Song,L.-S. Lu,H.-C. Shen,C.-H. Lee,J.-Y. Wu,Y.-T. Chen,V.B. Kraus,C.-C. Wu

DOI: https://doi.org/10.1016/j.joca.2014.12.020

IF: 7.507

2015-04-01

Osteoarthritis and Cartilage

Abstract:OBJECTIVE: To identify disease relevant genes and pathways associated with knee Osteoarthritis (OA) progression in human subjects using medial and lateral compartment dominant OA knee tissue.DESIGN: Gene expression of knee cartilage was comprehensively assessed for three regions of interest from human medial dominant OA (n = 10) and non-OA (n = 6) specimens. Histology and gene expression were compared for the regions with minimal degeneration, moderate degeneration and significant degeneration. Agilent whole-genome microarray was performed and data were analyzed using Agilent GeneSpring GX11.5. Significant differentially regulated genes were further investigated by Ingenuity Pathway Analysis (IPA) to identify functional categories. To confirm their association with disease severity as opposed to site within the knee, 30 differentially expressed genes, identified by microarray, were analyzed by quantitative reverse-transcription polymerase chain reaction on additional medial (n = 16) and lateral (n = 10) compartment dominant knee OA samples.RESULTS: A total of 767 genes were differentially expressed ≥ two-fold (P ≤ 0.05) in lesion compared to relatively intact regions. Analysis of these data by IPA predicted biological functions related to an imbalance of anabolism and catabolism of cartilage matrix components. Up-regulated expression of IL11, POSTN, TNFAIP6, and down-regulated expression of CHRDL2, MATN4, SPOCK3, VIT, PDE3B were significantly associated with OA progression and validated in both medial and lateral compartment dominant OA samples.CONCLUSIONS: Our study provides a strategy for identifying targets whose modification may have the potential to ameliorate pathological alternations and progression of disease in cartilage and to serve as biomarkers for identifying individuals susceptible to progression.

orthopedics,rheumatology
Osteoarthritis endotype discovery via clustering of biochemical marker data

Federico Angelini,Paweł Widera,Ali Mobasheri,Joseph Blair,André Struglics,Melanie Uebelhoer,Yves Henrotin,Anne Ca Marijnissen,Margreet Kloppenburg,Francisco J Blanco,Ida K Haugen,Francis Berenbaum,Christoph Ladel,Jonathan Larkin,Anne C Bay-Jensen,Jaume Bacardit

DOI: https://doi.org/10.1136/annrheumdis-2021-221763

Abstract:Objectives: Osteoarthritis (OA) patient stratification is an important challenge to design tailored treatments and drive drug development. Biochemical markers reflecting joint tissue turnover were measured in the IMI-APPROACH cohort at baseline and analysed using a machine learning approach in order to study OA-dominant phenotypes driven by the endotype-related clusters and discover the driving features and their disease-context meaning. Method: Data quality assessment was performed to design appropriate data preprocessing techniques. The k-means clustering algorithm was used to find dominant subgroups of patients based on the biochemical markers data. Classification models were trained to predict cluster membership, and Explainable AI techniques were used to interpret these to reveal the driving factors behind each cluster and identify phenotypes. Statistical analysis was performed to compare differences between clusters with respect to other markers in the IMI-APPROACH cohort and the longitudinal disease progression. Results: Three dominant endotypes were found, associated with three phenotypes: C1) low tissue turnover (low repair and articular cartilage/subchondral bone turnover), C2) structural damage (high bone formation/resorption, cartilage degradation) and C3) systemic inflammation (joint tissue degradation, inflammation, cartilage degradation). The method achieved consistent results in the FNIH/OAI cohort. C1 had the highest proportion of non-progressors. C2 was mostly linked to longitudinal structural progression, and C3 was linked to sustained or progressive pain. Conclusions: This work supports the existence of differential phenotypes in OA. The biomarker approach could potentially drive stratification for OA clinical trials and contribute to precision medicine strategies for OA progression in the future. Trial registration number: NCT03883568.
Characterization of clinical data for patient stratification in moderate osteoarthritis with support vector machines, regulatory network models, and verification against osteoarthritis Initiative data

Maria Segarra-Queralt,Mar Galofré,Laura Tio,Jordi Monfort,Joan Carlos Monllau,Gemma Piella,Jérôme Noailly

DOI: https://doi.org/10.1038/s41598-024-62212-x

IF: 4.6

2024-05-25

Scientific Reports

Abstract:Knee osteoarthritis (OA) diagnosis is based on symptoms, assessed through questionnaires such as the WOMAC. However, the inconsistency of pain recording and the discrepancy between joint phenotype and symptoms highlight the need for objective biomarkers in knee OA diagnosis. To this end, we study relationships among clinical and molecular data in a cohort of women (n = 51) with Kellgren–Lawrence grade 2–3 knee OA through a Support Vector Machine (SVM) and a regulation network model. Clinical descriptors (i.e., pain catastrophism, depression, functionality, joint pain, rigidity, sensitization and synovitis) are used to classify patients. A Youden's test is performed for each classifier to determine optimal binarization thresholds for the descriptors. Thresholds are tested against patient stratification according to baseline WOMAC data from the Osteoarthritis Initiative, and the mean accuracy is 0.97. For our cohort, the data used as SVM inputs are knee OA descriptors, synovial fluid proteomic measurements (n = 25), and transcription factor activation obtained from regulatory network model stimulated with the synovial fluid measurements. The relative weights after classification reflect input importance. The performance of each classifier is evaluated through ROC-AUC analysis. The best classifier with clinical data is pain catastrophism (AUC = 0.9), highly influenced by funcionality and pain sensetization, suggesting that kinesophobia is involved in pain perception. With synovial fluid proteins used as input, leptin strongly influences every classifier, suggesting the importance of low-grade inflammation. When transcription factors are used, the mean AUC is limited to 0.608, which can be related to the pleomorphic behaviour of osteoarthritic chondrocytes. Nevertheless, funcionality has an AUC of 0.7 with a decisive importance of FOXO downregulation. Though larger and longitudinal cohorts are needed, this unique combination of SVM and regulatory network model shall help to stratify knee OA patients more objectively.

multidisciplinary sciences
Identification and experimental validation of key genes in osteoarthritis based on machine learning algorithms and single-cell sequencing analysis

Enming Yu,Mingshu Zhang,Chunyang Xi,Jinglong Yan

DOI: https://doi.org/10.1016/j.heliyon.2024.e37047

IF: 3.776

2024-08-28

Heliyon

Abstract:Purpose: Osteoarthritis (OA) is a prevalent cause of disability in older adults. Identifying diagnostic markers for OA is essential for elucidating its mechanisms and facilitating early diagnosis. Methods: We analyzed 53 synovial tissue samples (n = 30 for OA, n = 23 for the control group) from two datasets in the Gene Express Omnibus (GEO) database. We identified differentially expressed genes (DEGs) between the groups and applied dimensionality reduction using six machine learning algorithms to pinpoint characteristic genes (key genes). We classified the OA samples into subtypes based on these key genes and explored the differences in biological functions and immune characteristics among subtypes, as well as the roles of the key genes. Additionally, we constructed a protein-protein interaction network to predict small molecules that target these genes. Further, we accessed synovial tissue sample data from the single-cell RNA dataset GSE152805, categorized the cells into various types, and examined variations in gene expression and their correlation with OA progression. Validation of key gene expression was conducted in cellular experiments using the qPCR method. Results: Four genes AGMAT, MAP3K8, PER1, and XIST, were identified as characteristic genes of OA. All can independently predict the occurrence of OA. With these genes, the OA samples can be clustered into two subtypes, which showed significant differences in functional pathways and immune infiltration. Eight cell types were obtained by analyzing the single-cell RNA data, with synovial intimal fibroblasts (SIF) accounting for the highest proportion in each sample. The key genes were found over-expressed in SIF and significantly correlated with OA progression and the content of immune cells (ICs). We validated the relative levels of key genes in OA and normal cartilage tissue cells, which showed an expression trend consistency with the bioinformatics result except for XIST. Conclusion: Four genes, AGMAT, MAP3K8, PER1, and XIST are closely related to the progression of OA, and play as diagnostic and predictive markers in early OA.
Energy value of agricultural spelt residue (Triticum spelta L.) – forgotten cultures

D. Kiš,Nives Jovičić,A. Matin,S. Kalambura,Sonja Vila,Sunčica Guberac

DOI: https://doi.org/10.17559/TV-20170406124003

2017-09-02

Abstract:Pir, krupnik ili dinkel (Lat. Triticum spelta) jedna je od najstarijih žitarica, a potjece iz Azije. Od broncanog doba do srednjeg vijeka u Europi je bio vrlo važna žitarica. Nakon upotrebe zrna u prehrambene svrhe ostaje biomasa pira kao nusproizvod odnosno otpad. Rastuce cijene fosilnih goriva i sve vece zabrinutosti oko klimatskih promjena stvaraju sve vecu potražnju za novim izvorima sirovine za održivu proizvodnju topline. U posljednjih nekoliko godina istraživanja su pokazala pozitivne ucinke uporabe poljoprivrednih ostataka za proizvodnju energije. Zrno pira prerađuje se u razlicite svrhe, dok pljeve, pljevice te stabljika zaostaju kao nusproizvod odnosno ostatak u proizvodnji. Stoga je znacajno provesti istraživanje kako bi se utvrdila energetska (goriva) svojstva pljeve i pljevice te stabljike pira. U radu su obuhvacene dvije sorte pira BcVigor i Ostro. Nakon prikupljenih i homogeniziranih uzoraka za svaku sortu određene su gornje i donje ogrjevne vrijednosti (Hg i Hd). Rezultati dobiveni u ovom istraživanju pokazali su da su pljeve i pljevice te stabljika pira, kao ostatak nakon upotrebe zrna u prehrambene svrhe, vrlo kvalitetna sirovina za proizvodnju energije zbog svoje visoke ogrjevne vrijednosti: gornja ogrijevna vrijednost stabljike sorte BcVigor iznosi 17.367 MJ/kg, a stabljike sorte Ostro 17.224 MJ/kg dok gornja ogrijevna vrijednost pljeve i pljevice sorte Ostro iznosi16.402 MJ/kg, a sorte BcVigor 16.650 MJ/kg.
Identification and Construction of a Disulfidptosis-Mediated Diagnostic Model and Associated Immune Microenvironment of Osteoarthritis from the Perspective of PPPM

DOI: https://doi.org/10.2147/jir.s462179

IF: 4.5

2024-06-12

Journal of Inflammation Research

Abstract:Kaibo Hu, 1, 2, &ast Yanghuan Ou, 1, &ast Leyang Xiao, 1, 2, &ast Ruonan Gu, 1, 2 Fei He, 1, 2 Jie Peng, 1, 2 Yuan Shu, 1, 2 Ting Li, 1, 2 Liang Hao 1 1 Department of Orthopedics, Second Affiliated Hospital of Nanchang University, Nanchang, 330006, People's Republic of China; 2 The Second Clinical Medical College, Nanchang University, Nanchang, 330006, People's Republic of China &astThese authors contributed equally to this work Correspondence: Liang Hao, Tel +86 136 0700 8562, Email Background: Osteoarthritis (OA) is a major cause of human disability. Despite receiving treatment, patients with the middle and late stage of OA have poor survival outcomes. Therefore, within the framework of predictive, preventive, and personalized medicine (PPPM/3PM), early personalized diagnosis of OA is particularly prominent. PPPM aims to accurately identify disease by integrating multiple omic techniques; however, the efficiency of currently available methods and biomarkers in predicting and diagnosing OA should be improved. Disulfidptosis, a novel programmed cell death mechanism and appeared in particular metabolic status, plays a mysterious characteristic in the occurrence and development of OA, which warrants further investigation. Methods: In this study, we integrated three public datasets from the Gene Expression Omnibus (GEO) database, including 26 OA samples and 20 normal samples. Via a series of bioinformatic analysis and machine learning, we identified the diagnostic biomarkers and several subtypes of OA. Moreover, the expression of these biomarkers were verified in our in-house cohort and the single cell dataset. Results: Three significant regulators of disulfidptosis (NCKAP1, OXSM, and SLC3A2) were identified through differential expression analysis and machine learning. And a nomogram constructed based on these three regulators exhibited ideal efficiency in predicting early- and late-stage OA. Furthermore, based on the expression of three regulators, we identified two disulfidptosis-related subtypes of OA with different infiltration of immune cells and personalized expression level of immune checkpoints. Notably, the expression of the three regulators was demonstrated in a single-cell RNA profile and verified in the synovial tissue in our in-house cohort including 6 OA patients and 6 normal people. Finally, an efficient disulfidptosis-mediated diagnostic model was constructed for OA, with the AUC value of 97.6923% in the training set and 93.3333% and 100% in two validation sets. Conclusion: Overall, with regard to PPPM, this study provided novel insights into the role of disulfidptosis regulators in the personalized diagnosis and treatment of OA. Keywords: osteoarthritis, disulfidptosis, perspective of predictive, preventive and personalized medicine, immune microenvironment, diagnostic model Osteoarthritis (OA) is a multifaceted degenerative disease that involves both inflammatory and metabolic factors. It is one of the common joint diseases that mostly affects the knees, hands, feet, hips and spine. 1 OA is more prevalent in women, the elderly population and patients with obesity. According to the recent statistical data reported by the World Health Organization (WHO), the prevalence of OA has increased from 12.3% to 21.6%. 2,3 The quality of life and motor functions of patients with end-stage OA are substantially deteriorated, which is a leading cause of disability and an important health concern worldwide. 4 Moreover, early diagnosis of OA remains a major challenge for clinicians. 5 Therefore, early and personalized detection, diagnosis, intervention and treatment are particularly crucial. With the development of modern medicine, predictive, preventive and personalized medicine (PPPM) has exhibited a thriving trend for future medical strategies. PPPM aims to continuously integrate the development trends of contemporary biomedical technology to provide novel insights into the early detection, diagnosis and treatment of diseases. 6,7 Unlike previous medical models, PPPM is committed to taking action before or in the early stages of a disease to suppress its occurrence and development. 8 At present, PPPM is used for the monitoring, prevention and early diagnosis of various diseases, especially some degenerative and chronic diseases. 7 Although the concepts of primary, secondary and tertiary prevention apply to the management of OA, the application of the PPPM framework is significantly limited in OA compared with cancer, di -Abstract Truncated-

immunology
Patterns of variation among baseline femoral and tibial cartilage thickness and clinical features: Data from the osteoarthritis initiative

Thomas H Keefe,Mary Catherine Minnig,Liubov Arbeeva,Marc Niethammer,Zhenlin Xu,Zhengyang Shen,Boqi Chen,Daniel B Nissman,Yvonne M Golightly,J S Marron,Amanda E Nelson

DOI: https://doi.org/10.1016/j.ocarto.2023.100334

2023-01-24

Abstract:Objective: To employ novel methodologies to identify phenotypes in knee OA based on variation among three baseline data blocks: 1) femoral cartilage thickness, 2) tibial cartilage thickness, and 3) participant characteristics and clinical features. Methods: Baseline data were from 3321 Osteoarthritis Initiative (OAI) participants with available cartilage thickness maps (6265 knees) and 77 clinical features. Cartilage maps were obtained from 3D DESS MR images using a deep-learning based segmentation approach and an atlas-based analysis developed by our group. Angle-based Joint and Individual Variation Explained (AJIVE) was used to capture and quantify variation, both shared among multiple data blocks and individual to each block, and to determine statistical significance. Results: Three major modes of variation were shared across the three data blocks. Mode 1 reflected overall thicker cartilage among men, those with higher education, and greater knee forces; Mode 2 showed associations between worsening Kellgren-Lawrence Grade, medial cartilage thinning, and worsening symptoms; and Mode 3 contrasted lateral and medial-predominant cartilage loss associated with BMI and malalignment. Each data block also demonstrated individual, independent modes of variation consistent with the known discordance between symptoms and structure in knee OA and reflecting the importance of features such as physical function, symptoms, and comorbid conditions independent of structural damage. Conclusions: This exploratory analysis, combining the rich OAI dataset with novel methods for determining and visualizing cartilage thickness, reinforces known associations in knee OA while providing insights into the potential for data integration in knee OA phenotyping.
Rounded atelectasis and mesothelioma.

R. Munden,H. Libshitz

DOI: https://doi.org/10.2214/AJR.170.6.9609165

1998-06-01

Abstract:OBJECTIVE The purpose of this article is to report the coexistence of rounded atelectasis with malignant pleural mesothelioma as revealed by radiography and CT. CONCLUSION Our five cases show the coexistence of rounded atelectasis and malignant mesothelioma. If rounded atelectasis is associated with a pleural effusion, a pleural mass with or without chest-wall invasion, or thickened pleura not adjacent to the rounded atelectasis, malignant mesothelioma should be strongly considered.

DO "ANORECTIC" DRUGS PRODUCE WEIGHT LOSS BY APPETITE SUPPRESSION?

Disease progression and clinical outcomes in latent osteoarthritis phenotypes: Data from the Osteoarthritis Initiative

A clinical model to predict the progression of knee osteoarthritis: data from Dryad

Phenotypes of osteoarthritis-related knee pain and their transition over time: data from the osteoarthritis initiative

Identifying Robust Risk Factors for Knee Osteoarthritis Progression: An Evolutionary Machine Learning Approach

Multivariate information transmission

Multimodal Machine Learning-based Knee Osteoarthritis Progression Prediction from Plain Radiographs and Clinical Data

Predicting the onset of end-stage knee osteoarthritis over two- and five-years using machine learning

Data-driven identification of predictive risk biomarkers for subgroups of osteoarthritis using interpretable machine learning

A warning machine learning algorithm for early knee osteoarthritis structural progressor patient screening

Identifying the Phenotypic and Temporal Heterogeneity of Knee Osteoarthritis: Data From the Osteoarthritis Initiative

Identification of Biomarkers Associated with Diagnosis of Osteoarthritis Patients Based on Bioinformatics and Machine Learning

Multi-classifier prediction of knee osteoarthritis progression from incomplete imbalanced longitudinal data

Insights into osteoarthritis progression revealed by analyses of both knee tibiofemoral compartments

Osteoarthritis endotype discovery via clustering of biochemical marker data

Characterization of clinical data for patient stratification in moderate osteoarthritis with support vector machines, regulatory network models, and verification against osteoarthritis Initiative data

Identification and experimental validation of key genes in osteoarthritis based on machine learning algorithms and single-cell sequencing analysis

Energy value of agricultural spelt residue (Triticum spelta L.) – forgotten cultures

Identification and Construction of a Disulfidptosis-Mediated Diagnostic Model and Associated Immune Microenvironment of Osteoarthritis from the Perspective of PPPM

Patterns of variation among baseline femoral and tibial cartilage thickness and clinical features: Data from the osteoarthritis initiative

Rounded atelectasis and mesothelioma.